. Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome. Prog Brain Res. 2020;251:245-268. Epub 2019 Nov 1 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Research Models

  1. Ts65Dn